Middle East Respiratory Syndrome
📧 Sign up to get email alerts when something new happens for Middle East Respiratory Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers [Phase 2]
Phase 2 clinical trial update on INO-4700 for Middle East respiratory syndrome (MERS) showing safety, tolerability, and immunogenicity in he…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS [Phase 1]
Phase 1 study evaluating safety and immunogenicity of the candidate vaccine MVA-MERS-S_DF-1 against Middle East respiratory syndrome has com…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Respiratory Virus Hospitalization Study (FLU 003 Plus)
A clinical trial update for FLU 003 Plus on respiratory virus hospitalizations shows the study status as completed, and lists influenza, Mid…
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease [Phase 2]
Phase 2 clinical trial assessing oral lactoferrin as a safe antiviral and immunoregulatory treatment for COVID-19 and related coronavirus in…
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Study of Safety and Immunogenicity of BVRS-GamVac [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing safety and immunogenicity of BVRS-GamVac for MERS is ongoing with unknown status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Study of Safety and Immunogenicity of BVRS-GamVac-Combi [Phase 1, Phase 2]
Phase 1/2 trial update on safety and immunogenicity of BVRS-GamVac-Combi for MERS is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S [Phase 1]
Phase 1 clinical trial evaluating safety, tolerability and immunogenicity of the MVA-MERS-S vaccine candidate for Middle East Respiratory Sy…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051 [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating safety, tolerability, pharmacokinetics and immunogenicity of…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults [Phase 1]
Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of SAB-301 in healthy adults; the study completed and results were poste…
-
CLINICAL_TRIALS research · 2016-09-01Clinical Trial Update: Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV)
A completed clinical trial analysis examining human-to-human transmission of Middle East respiratory syndrome coronavirus (MERS-CoV).
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Saudi Outcomes of ECMO-treated MERS-CoV Patients [Phase 1]
This update reports outcomes from a Phase 1 trial in Saudi Arabia evaluating ECMO for patients with Middle East respiratory syndrome coronav…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Seroprevalence of MERS-CoV IgG in Healthcare Workers
A completed clinical trial assessed the seroprevalence of MERS-CoV IgG antibodies in healthcare workers.